- Home
- LMFA vs NLSP Comparison
LMFA vs NLSP Comparison
Compare LMFA & NLSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LMFA
- NLSP
- Stock Information
- Founded
- LMFA 2008
- NLSP 2015
- Country
- LMFA United States
- NLSP Switzerland
- Employees
- LMFA N/A
- NLSP N/A
- Industry
- LMFA Finance: Consumer Services
- NLSP Biotechnology: Pharmaceutical Preparations
- Sector
- LMFA Finance
- NLSP Health Care
- Exchange
- LMFA Nasdaq
- NLSP Nasdaq
- Market Cap
- LMFA 7.0M
- NLSP 5.9M
- IPO Year
- LMFA 2015
- NLSP 2021
- Fundamental
- Price
- LMFA $1.43
- NLSP $1.50
- Analyst Decision
- LMFA Hold
- NLSP
- Analyst Count
- LMFA 1
- NLSP 0
- Target Price
- LMFA N/A
- NLSP N/A
- AVG Volume (30 Days)
- LMFA 36.4K
- NLSP 102.5K
- Earning Date
- LMFA 05-15-2025
- NLSP 05-14-2025
- Dividend Yield
- LMFA N/A
- NLSP N/A
- EPS Growth
- LMFA N/A
- NLSP N/A
- EPS
- LMFA N/A
- NLSP N/A
- Revenue
- LMFA $10,555,948.00
- NLSP N/A
- Revenue This Year
- LMFA $0.98
- NLSP N/A
- Revenue Next Year
- LMFA $4.31
- NLSP N/A
- P/E Ratio
- LMFA N/A
- NLSP N/A
- Revenue Growth
- LMFA N/A
- NLSP N/A
- 52 Week Low
- LMFA $1.02
- NLSP $1.30
- 52 Week High
- LMFA $6.11
- NLSP $18.40
- Technical
- Relative Strength Index (RSI)
- LMFA 57.42
- NLSP 49.86
- Support Level
- LMFA $1.11
- NLSP $1.38
- Resistance Level
- LMFA $1.50
- NLSP $1.53
- Average True Range (ATR)
- LMFA 0.13
- NLSP 0.09
- MACD
- LMFA 0.04
- NLSP 0.02
- Stochastic Oscillator
- LMFA 85.36
- NLSP 64.91
About LMFA LM Funding America Inc.
LM Funding America Inc is a financial services company. The company provides funding to nonprofit community associations located in the state of Florida and to nonprofit community associations in the states of Washington and Colorado. Its products include Original Product and New Neighbor Guaranty. Its original product offering consists of providing funding to Associations by purchasing their rights under delinquent accounts that are selected by the Associations arising from unpaid Association assessments. It currently has two lines of business recently commenced cryptocurrency mining business and historical specialty finance business. The Company has two operating segments: Specialty Finance and Mining Operations, which generate the majority of its revenue.
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.